Glucocorticoids regulate extracellular matrix metabolism in human vocal fold fibroblasts

Laryngoscope

Volumn 121, Issue 9, 2011, Pages 1915-1919

  Zhou, Hang ^a   Sivasankar, Mahalakshmi ^b   Kraus, Dennis H ^c   Sandulache, Vlad C ^d   Amin, Milan ^a   Branski, Ryan C ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

dexamethasone; glucocorticoids; scar; steroids; Vocal fold; voice

Indexed keywords

COLLAGEN; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; INTERSTITIAL COLLAGENASE; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL METABOLISM; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; VOCAL CORD; VOCAL CORD DISORDER; VOCAL FOLD SCAR;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CELL LINE; COLLAGEN; DEXAMETHASONE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXTRACELLULAR MATRIX; FIBROBLASTS; GLUCOCORTICOIDS; HUMANS; IMMUNOENZYME TECHNIQUES; LARYNGECTOMY; MATRIX METALLOPROTEINASE 1; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA; VOCAL CORDS;

EID: 80052082416     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.21920     Document Type: Article

References (32)

1. Mortensen M, Woo P,. Office steroid injections of the larynx. Laryngoscope 2006; 116: 1735-1739. (Pubitemid 44511352)
2. Tateya I, Omori K, Kojima H, Hirano S, Kaneko K, Ito J,. Steroid injection to vocal nodules using fiberoptic laryngeal surgery under topical anesthesia. Eur Arch Otorhinolaryngol 2004; 261: 489-492. (Pubitemid 39506426)
3. Rosen CA, Amin MR, Sulica L, et al. Advances in office-based diagnosis and treatment in laryngology. Laryngoscope 2009; 119: S185-S212.
4. Berman B, Bieley HC,. Keloids. J Am Acad Dermatol 1995; 33: 117-123.
5. Lawrence WT,. In search of the optimal treatment of keloids: Report of a series and a review of the literature. Ann Plast Surg 1991; 27: 164-178.
6. Sherris DA, Larrabee WF, Murakami CS,. Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin North Am 1995; 28: 1057-1068.
7. Boyadjiev C, Popchristova E, Mazgalova J,. Histomorphologic changes in keloids treated with Kenacort. J Trauma 1995; 38: 299-302.
8. Darzi MA, Chowdri NA, Kaul SK, Khan M,. Evaluation of various methods of treating keloids and hypertrophic scars: A 10-year follow up study. Br J Plast Surg 1992; 45: 374-379.
9. Tang YW,. Intra- and postoperative steroid injections for keloids and hypertrophic scars. Br J Plast Surg 1992; 45: 371-373.
10. Kiil J,. Keloids treated with topical injections of triamcinolone acetonide (kenalog): Immediate and long-term results. Scand J Plast Reconstr Surg 1977; 11: 169-172. (Pubitemid 8289059)
11. Alaish SM, Yager DR, Diegelmann RF, Cohen IK,. Hyaluronic acid metabolism in keloid fibroblasts. J Pediatr Surg 1995; 30: 949-952.
12. Gadson PF, Russell JD, Russell SB,. Glucocorticoid receptors in human fibroblasts derived from normal dermis and keloid tissue. J Biol Chem 1984; 259: 11236-11241. (Pubitemid 14007773)
13. Krusche T, Worret WI,. Mechanical properties of keloids in vivo during treatment with intralesional triamcinolone acetonide. Arch Dermatol Res 1995; 287: 289-293.
14. McCoy BJ, Diegelmann RF, Cohen IK,. In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc Soc Exp Biol Med 1980; 163: 216-222. (Pubitemid 10111253)
15. Kauh YC, Rouda S, Mondragon G, et al. Major suppression of pro-alpha1 (I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol 1997; 37: 586-589. (Pubitemid 27446729)
16. Lavker RM, Schechter NM,. Cutaneous mast cell depletion results from topical corticosteroid usage. J Immunol 1985; 135: 2368-2373. (Pubitemid 16217122)
17. Wu WS, Wang FS, Yang KD, Huang CC, Kuo YR,. Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol 2006; 126: 1264-1271. (Pubitemid 43997906)
18. Meisler N, Keefer KA, Ehrlich HP, Yager DR, Myers-Parrelli J, Cutroneo KR,. Dexamethasone abrogates the fibrogenic effect of transforming growth factor-beta in rat granuloma and granulation tissue fibroblasts. J Invest Dermatol 1997; 108: 285-289. (Pubitemid 27116225)
19. Rosenkrans JA,. Viral croup: current diagnosis and treatment. Mayo Clin Proc 1998; 73: 1102-1106.
20. Kairys SW, Olmstead EM, O'Connor GT,. Steroid treatment of laryngotracheitis: a meta-analysis of the evidence from randomized trials. Pediatrics 1989; 83: 683-693. (Pubitemid 19120509)
21. Ossoff RH, Wolff AP, Ballenger JJ,. Acute epiglottitis I adults: experience with fifteen cases. Laryngoscope 1980; 90: 1155-1161. (Pubitemid 10087281)
22. Krespi YP, Mitrani M, Husain S, Meltzer CJ,. Treatment of laryngeal sarcoidosis with intralesional steroid injection. Ann Otol Rhinol Laryngol 1987; 96: 713-715. (Pubitemid 18021420)
23. Tateya I, Omori K, Kojima H, Hirano S, Kaneko K, Ito J,. Steroid injection for Reinke's edema using fiberoptic laryngeal surgery. Acta Otolaryngol 2003; 122: 417-420. (Pubitemid 36520973)
24. Campagnolo AM, Tsuji DH, Sennes LU, Imamura R, Saldiva PHN,. Histologic study of acute vocal fold wound healing after corticosteroid injection in a rabbit model. Ann Otol Rhinol Laryngol 2010; 119: 133-139.
25. Branski RC, Barbieri SS, Weksler BB, et al. The effects of transforming growth factor-beta1 on human vocal fold fibroblasts. Ann Otol Rhinol Laryngol 2009; 118: 218-226.
26. Kellner D, Chen J, Richardson I, et al. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction. J Urol 2006; 176: 806-812. (Pubitemid 43927915)
27. Chang WC, Roth GS,. Changes in the mechanism of steroid action during aging. J Biol Chem 1979; 11: 889-892. (Pubitemid 9249103)
28. Okret S, Poellinger L, Dong Y, Gustaffsson JA,. Down-regulation of glucocorticoid receptor mRNA by glucocorticoid hormones and recognition by the receptor of a specific binding sequence within a receptor cDNA clone. Proc Natl Acad Sci U S A 1986; 83: 5899-5903. (Pubitemid 16000621)
29. Sivasankar M, Erickson E, Rosenblatt M, Branski RC,. Hypertonic challenge to porcine vocal folds: Effects on epithelial barrier function. Otolaryngol Head Neck Surg 2010; 142: 79-84.
30. Rousseau B, Suehiro A, Echemendia N, Sivasankar M,. Raised intensity phonation compromises vocal fold epithelial barrier integrity. Laryngoscope 2011; 121: 346-351.
31. Zettl KS, Sjaastad MD, Riskin PM, Parry G, Machen TE, Firestone GL,. Glucocorticoid-induced formation of tight junctions in mouse mammary epithelial cells in vitro. Proc Natl Acad Sci U S A 1992; 89: 9069-9073.
32. Marks R, Sawyer M, Barlow JW,. Glucocorticoid-induced vasoconstriction in canine skin Arch Dermatol Res 1985; 277: 318-322. (Pubitemid 15114241)